Thomas Bachelot
0000-0002-0866-9484
Centre Léon Bérard
5 papers found
Refreshing results…
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
Phase Ib Study of Ribociclib Plus Fulvestrant and Ribociclib Plus Fulvestrant Plus PI3K-Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer
Rapalog-mediated repression of Tribbles pseudokinase 3 regulates pre-mRNA splicing
Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study
Physical activity preferences before and after participation in a 6‐month physical activity intervention among women with metastatic breast cancer
Missing publications? Search for publications with a matching author name.